Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer
The University of Texas MD Anderson Cancer Center · Northwestern University · +2 more institutions
Abstract
Abstract The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) involves a significant accumulation of fibroblasts as part of the host response to cancer. Using single-cell RNA sequencing, multiplex immunostaining, and several genetic mouse models, we identify carcinoma-associated fibroblasts (CAF) with opposing functions in PDAC progression. Depletion of fibroblast activation protein (FAP)+ CAFs results in increased survival, in contrast to depletion of alpha smooth muscle actin (αSMA)+ CAFs, which leads to decreased survival. Tumor-promoting FAP+ CAFs (TP-CAF) and tumor-restraining αSMA+ CAFs (TR-CAF) differentially regulate cancer-associated pathways and accumulation of regulatory T cells.…
Citation impact
- FWCI
- 29.74
- Percentile
- 100%
- References
- 77
Authors
16- KMKathleen M. McAndrews
The University of Texas MD Anderson Cancer Center
- YCYang Chen
The University of Texas MD Anderson Cancer Center
- JKJ. Kebbeh Darpolor
The University of Texas MD Anderson Cancer Center
- XZXiaofeng Zheng
The University of Texas MD Anderson Cancer Center
- SYSujuan Yang
The University of Texas MD Anderson Cancer Center
Topics & keywords
- Pancreatic cancer
- Cancer
- Identification (biology)
- Cancer research
- Biology
- Cancer-Associated Fibroblasts
- Carcinoma
- Computational biology
- Good health and well-being
Funding
- SWSid W. Richardson Foundation
- CPCancer Prevention and Research Institute of TexasAwards: P30CA016672, UL1TR000371, RP150231
- NINational Institutes of HealthAwards: P30CA016672, P01CA117969, UL1TR000371, NIH P30CA016672
- UOUniversity of Texas MD Anderson Cancer CenterAwards: P30CA016672, NIH P30CA016672
- CFCenter for Clinical and Translational Sciences, University of Texas Health Science Center at HoustonAward: UL1TR000371
- NCNational Cancer InstituteAwards: P01CA117969, UL1TR000371, P30CA016672